Eating Disorders An International Comprehensive View /
| Autor Corporativo: | |
|---|---|
| Outros Autores: | , , , , , |
| Resumo: | 170 illus., 50 illus. in color. text |
| Idioma: | inglês |
| Publicado em: |
Cham :
Springer Nature Switzerland : Imprint: Springer,
2023.
|
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/978-3-030-97416-9 |
| Formato: | Recurso Eletrônico Livro |
Sumário:
- Section 1: Introduction: 1.1: Definitions and Clinical features
- 1.2: Epidemiology
- 1.3: Aetiology
- 1.4: Treatment
- 1.5: Family and peers
- 1.6: Outcome and course
- 1.7: Conclusions
- Section 2 : Definitions and classification: 2.1 DSM 5
- 2.2 ICD 11
- 2.3 Additional phenotypes
- Section 3: Epidemiology: 3.1: EDs in “Western” countries
- 3.2: East Asia
- 3.3: South Asia
- 3.4: Africa
- 3.5: Middle East
- 3.6: Indigenous peoples
- 3.7: Peoples of cultural and linguistic diversity (CALD)
- 3.8: Eating disorders and pandemics
- 3.9: Latin America
- 3.10: Eastern Europe.-Section 4: Psychosocial Aetiology: 4.1: Overview of risk factors for Eds
- 4.2: Personality vulnerabilities as risk factor for ED
- 4.3: Family as a risk factor for ED
- 4.4: Education as a risk factor for ED
- 4.5: Peer group as a risk factor for ED
- 4.6: Sport and exercise factors as risk factors for ED
- 4.7: Social media as risk factor for ED
- 4.8: Trauma and risk as risk factorsfor ED
- Section 5: Clinical features: 5.1: Hormonal
- 5.2: Psychological
- 5.3: Physical
- 5.4: Familial
- 5.5: Men
- 5.6: Diabetes type 1
- 5.7: Obesity with EDs and Bariatric surgery
- 5.8: Psychiatric comorbidity
- 5.9: ASD
- 5.10: EDs in LGBT community
- Section 6: Neurobiology of Eds: 6.1: Neuroimaging
- 6.2: Metabolomics
- 6.3: Gut-Brain axis
- 6.4: Genetics
- 6.5: Immunology, Cytokines
- 6.6: Brain neurotransmitters
- 6.7 The hypothalamus-pituitary-adrenal axis
- 6.8 Central and peripheral modulators of appetite
- 6.9: Brain Neurodevelopmental changes in eating Disorders
- Section 7: Treatment: Subsection 7a: Initial response following presentation: 7a.1: Specialist assessment
- 7a.2: Prevention
- 7a.3: Primary care
- 7a.4: Early intervention
- 7a.5: Barriers to treatment
- 7a.6: Emergency and general hospital treatment including refeeding
- Subsection 7b: Evidence based psychological approaches: 7b.1: CBT
- 7b.2: Family approaches
- 7b.3: SSCM
- 7b.4: MANTRA
- 7b.5: Dialectical Behaviour Therapy
- 7b.6: Integrative Cognitive Affective Therapy
- 7b.7: Guided self help
- 7b.8: Psychodynamic therapies. MBT
- Subsection 7c: Intensive interventions: 7c.1: Day care and home treatment
- 7c.2: Inpatient care
- Subsection 7d: Emerging areas: 7d.1: Brain treatments
- 7d.2: Drug treatment
- 7d.3: Ethical issues in treatment
- 7d.4: Lived experience of illness and treatment
- 7d.5: CFT
- 7d.6: EMDR, Imagery rescripting
- 7d.7: Internet and tele-therapy
- 7d.8: Psychoeducation
- 7d.9: Obesity and Eds
- Section 8: Family, peers, carers: 8.1: Families in EDs: an attachment perspective
- 8.2: Relationships with peers
- 8.3 Siblings
- 8.4: Couples
- 8.5: Mothers and pregnant women with Eds
- 8.6: Carers and family members
- 8.7: Peer relationships and recovered peer mentors in recovery
- 8.8 Voluntary bodies
- Section 9: Outcome: 9.1: AN
- 9.2: BN
- 9.3: BED
- 9.4: ARFID
- 9.5: OSFED/UFED
- 9.6: Severe and Enduring Eds
- Section 10: Conclusions.